Korro Bio (KRRO) Research & Development (2018 - 2026)
Korro Bio (KRRO) recorded Research & Development of $13.59 million in Q2 2026, down 32.5% from $20.14 million a year earlier but up 4.9% from the prior quarter.
Powered by 
Analysis
Korro Bio (KRRO) Research & Development (2018 - 2026) Analysis & Trends
On a TTM basis, Korro Bio's Research & Development came in at $51.34 million as of Jun 30, 2026, down 29.5% year-over-year; for FY2025, it was $65.58 million, up 3.0% from FY2024.
- Annual Research & Development has increased for three straight years, with a five-year compound annual growth rate of 11.9% (FY2020 to FY2025).
- Across earlier years, Research & Development came in at $63.64 million in FY2024 (+11.2%), $57.25 million in FY2023 (+35.7%), $42.2 million in FY2022 (-30.7%) and $60.92 million in FY2021 (+62.8%).
- Quarterly Research & Development has ranged from $3.43 million in Q4 2022 to $20.14 million in Q2 2025 over the past five years.
- On a year-over-year basis, Research & Development has declined for four consecutive quarters, with an average decline of 3.6% over the last eight quarters.
- Peak year-over-year performance for Research & Development in the last five years was growth of 349.4% in Q4 2023, against a decline of 73.1% in Q4 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at $12.95 million (Q1 2026), $10.99 million (Q4 2025) and $13.82 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 4.25 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 4.65 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 2.57 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 4.54 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 3.89 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 2.11 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 1.61 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 3.02 Bn |
| 10 | Korro Bio | 281.05 Mn | -128.11 Mn | - | 12.10 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 12.10 Mn |
| Jun 30, 2026 | 13.59 Mn |
| Mar 31, 2026 | 12.95 Mn |
| Dec 31, 2025 | 11.88 Mn |
| Sep 30, 2025 | 13.82 Mn |
| Jun 30, 2025 | 20.14 Mn |
| Mar 31, 2025 | 19.74 Mn |
| Dec 31, 2024 | 16.96 Mn |
| Sep 30, 2024 | 15.96 Mn |
| Jun 30, 2024 | 17.14 Mn |
| Mar 31, 2024 | 13.57 Mn |
| Dec 31, 2023 | 15.42 Mn |
| Sep 30, 2023 | 14.01 Mn |
| Jun 30, 2023 | 13.13 Mn |
| Mar 31, 2023 | 14.69 Mn |
| Dec 31, 2022 | 3.43 Mn |
| Sep 30, 2022 | 11.72 Mn |
| Jun 30, 2022 | 13.27 Mn |
| Mar 31, 2022 | 13.78 Mn |
| Dec 31, 2021 | 12.75 Mn |
API Access
Korro Bio Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=KRRO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "KRRO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=KRRO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();